Molly Dean, MSW, policy advisor at Siftwell, discusses how states have encouraged managed care entities to invest in local communities, build partnerships with nonprofits, and support social determinants of health initiatives.
As Medicaid agencies reprocure managed care programs, states are increasingly pressing health plans to address the challenges of rural health care deserts. Molly Dean, MSW, policy advisor at Siftwell, discusses how states have encouraged managed care entities to invest in local communities, build partnerships with nonprofits, and support social determinants of health initiatives in an interview with The American Journal of Care®. However, with Coronavirus Aid, Relief, and Economic Security (CARES) funds gone and financial pressures mounting, states must now reconsider how they structure requirements for managed care organizations to ensure sustained access to care in rural areas.
This transcript has been lightly edited; captions were auto-generated.
Transcript
Can you discuss the efforts aimed at improving managed care in rural health care deserts?
I think a couple of things that we've seen over the last several years, it's been a really rich time of Medicaid agencies reprocuring their managed care programs. Many states have looked to that opportunity to ask managed care entities this very question: What are you going to do about the rural areas of the state? Oftentimes, that looks like either a requirement or a strong recommendation to invest, to think through collaboratives, to understand the not-for-profit community, who is doing work. How do you fund them? How do you make that an extension of what you're making available by virtue of resource and the provision of health care services in these rural communities. That's everything from supporting local food banks, domestic violence shelters, what have you.
There has been an intentional request of the managed care plans to take their resources, their relationships, their competencies, and establish a presence, if you will. But also, more importantly, relationships with provider communities and entities that help care for social determinants of health gaps, that's been requested. We have seen that. I think the other piece of that is the "now"—like, now what? We are at a time where, for most states, the managed care rates, there's no longer a cushion, the CARES Act dollars have gone away. There's a squeeze that managed care entities are feeling there from a financial standpoint, all have requirements to invest back in states, back in people.
That's long standing on the other side of the Affordable Care Act. But what does that look like now? And I think it is going to be really important that states consider what they are requiring and expecting their managed care companies to maintain in terms of these relationships, particularly the relationships that are forged in these rural areas to ensure that people have the access to both the provision of health care again, as well as the social determinant of health needs being met by virtue of these relationships.
In some areas, it's been kind of voluntary; states haven't been very prescriptive in what they're asking of the health plans. But I think absent the ability to use direct Medicaid funding to pay for some of these things that that's going to be an ask, which then goes back to the real importance of understanding the value of, "we're no longer able to just throw money to all the various sundry, community-based organizations, because it looks good when I'm applying For an RFP [request for proposal]." The strategy, and the strategic nature, have to be in play, so that the investments for these managed care entities are thoughtful, but more importantly, informed by understanding the real needs of members, and to your question, the real needs of members in rural locations that otherwise will not have access to to care.
Reduced Rehospitalizations and Potential Cost Savings With Orca-T for Acute Leukemia, MDS
April 11th 2025Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
National Data Show Rising Risk, Cost of CKD in Patients With Acute Myocardial Infarction
April 10th 2025A series of new studies from the National Kidney Foundation Spring Clinical Meeting exhibit the association between impaired kidney function and prolonged hospital stays, higher charges, and greater resource utilization.
Read More
Survey Finds Slow Start on CMS Interoperability Rule Implementation
April 10th 2025With deadlines looming in 2026 and 2027 for compliance with the CMS Advancing Interoperability and Improving Prior Authorization Final Rule, a survey indicates a concerning lack of readiness among payers and providers to meet the new requirements for data sharing.
Read More